Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

GLOBAL BLOOD THERAPEUTICS, INC.

(GBT)
  Rapport
Vertraagde tijd Nasdaq  -  22:00 04-10-2022
68.49 USD   +0.01%
07/09Verkoop met voorkennis: Global Blood Therapeutics
MT
19/08Insider verkoop: Global Blood Therapeutics
MT
12/08Biotechaandelen vestigen hoop op opleving door M&A-stimulans
MR
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciënConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiële publicatiesSectornieuws
Nieuws in andere talen op GLOBAL BLOOD THERAPEUTICS, INC.
05/10Global Blood Therapeutics, Inc. : Entry into a Material Definitive Agreement, Termination ..
05/10Pfizer : finalise l'acquisition de Global Blood Therapeutics
30/09Global Blood Therapeutics, Inc. : Submission of Matters to a Vote of Security Holders, Oth..
23/09Global Blood Therapeutics, Inc. : Other Events (form 8-K)
16/09GBT Supports the Sickle Cell Disease Treatment Centers Act of 2022
08/09GBT and Sickle Cell Disease Association of America to Host 11th Annual Sickle Cell Dise..
07/09Insider Sell: Global Blood Therapeutics
31/08Global Blood Therapeutics Investor A : Kahn Swick & Foti, LLC Investigates Adequacy of Pri..
19/08Insider Sell: Global Blood Therapeutics
12/08Biotech stocks pin bounce back hopes on M&A boost
10/08North American Morning Briefing: Caution -2-
10/08Pfizer spending spree filters to Biopharma
09/08North American Morning Briefing: Stocks to -2-
09/08Global Blood : Q2 Earnings Snapshot
09/08BioPharma Credit To Receive Loan Prepayment Following Pfizer's Takeover Of Global Blood..
09/08Pfizer scoops up Global Blood Therapeutics in $5.4bn deal
09/08Global Blood Therapeutics Investor A : Kahn Swick & Foti, LLC Investigates Adequacy of Pri..
08/08Health Care Up Amid Deal Activity -- Health Care Roundup
08/08Pfizer compra Global Blood Therapeutics en un acuerdo de 5.400 millones de dólares
08/08LATE BRIEFING - Unternehmen und Märkte -2-
08/08Résumé des principales informations économiques du lundi 8 août 2022
08/08Pfizer Strikes $5.4 Billion Buyout Deal For Global Blood Therapeutics, Eyeing Sickle Ce..
08/08Pfizer spends billions on another takeover
08/08Pfizer buying spree continues with $5.4B hematology deal
08/08Pfizer acquista Global Blood Therapeutics per 5,4 mld dollari
08/08Sector Update: Health Care Stocks Edge Higher Early Monday
08/08Wall Street monte, les rendements reculent, le plan Biden en soutien
08/08Sector Update: Health Care
08/08Dpa-AFX-Überblick: UNTERNEHMEN vom 08.08.2022 - 15.15 Uhr
08/08Pfizer annonce le rachat de Global Blood Therapeutics
08/08Les valeurs à suivre aujourd'hui à Wall Street- Lundi 8 août 2022
08/08Aktien New York Ausblick: Gewinne - Zinspolitik der Notenbanken..
08/08Lost in inflation
08/08Pfizer will Global Blood Therapeutics für 5,4 Milliarden US-Dollar kaufen
08/08Pfizer : acquiert Global Blood Therapeutics (GBT) pour 5,4 milliards de dollars
08/08Pfizer Seals $5.4 Billion Deal to Buy Sickle Cell Drugmaker Global Blood Therapeutics
08/08Pfizer : acquisition de Global Blood Therapeutics
08/08Global Blood Therapeutics : Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion t..
08/08Pfizer to Buy Global Blood Therapeutics for $68.50/Share
08/08GLOBAL BLOOD THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL COND..
08/08Global Blood Therapeutics, Inc. : Entry into a Material Definitive Agreement, Amendments t..
08/08Global Blood Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six..
08/08Flush with cash, Pfizer buys Global Blood Therapeutics in $5.4 bln deal
08/08Pfizer to buy Global Blood Therapeutics in $5.4 billion deal
08/08Pfizer Reaches $5.4 Billion Deal For Global Blood Therapeutics - WSJ
08/08Pfizer reaches $5.4 billion deal for global blood therapeutics -…
08/08USA-Les valeurs à suivre à Wall Street (actualisé)
08/08Achats & ventes en pagaille : Planète Bourse du lundi 8 août..
08/08Global Blood Therapeutics Shares Rise Premarket After Pfizer Deal
08/08MÄRKTE EUROPA/DAX kräftig erholt - Versorger im Blick
08/08MÄRKTE EUROPA/DAX etwas höher erwartet
08/08Pfizer Nears $5 Billion Deal to Purchase Global Blood Therapeutics
08/08Pfizer Inc. (NYSE:PFE) entered into a definitive agreement to acquire ..
06/08Pfizer en négociation pour racheter Global Blood Therapeutics pour 5 mds USD
05/08MÄRKTE USA/Börsen zwischen Konjunkturhoffnung und Zinsangest gefangen
05/08Pfizer In Advanced Talks to Acquire Global Blood Therapeutics for $5 Billion, WSJ Says
05/08MÄRKTE USA/Wall Street mit Zinsängsten im Minus
05/08Pfizer Reportedly in Advanced Talks to Buy Global Blood Therapeutics for $5 Billion
05/08Pfizer in advanced talks to buy Global Blood Therapeutics for $5 bln - WSJ
05/08Pfizer in advanced talks to buy Global Blood Therapeutics for $5 billion - WSJ
05/08Pfizer In Advanced Talks to Buy Global Blood Therap..
04/08GBT Announces New Employment Inducement Grants
04/08Top Midday Gainers
04/08Global Blood Therapeutics Shares Surge Midday on Takeover Target Report
03/08GBT Announces Participation at the Wedbush PacGrow Healthcare Conference
01/08GBT to Announce Second Quarter 2022 Financial Results on Monday, August 8, 2022
29/07GBT to Announce Second Quarter 2022 Financial Results on Monday, August 8, 2022
27/07Global Blood Therapeutics, Inc. - MHRA Grants Marketing Authorization for GBT's Oxbryta..
26/07Global Blood Therapeutics : MHRA Grants Marketing Authorization for GBT's Oxbryta® (voxelo..
26/07Global Blood Therapeutics, Inc. : Other Events, Financial Statements and Exhibits (form 8-..
26/07MHRA Grants Marketing Authorization for Global Blood Therapeutics, Inc.'s Oxbryta for U..
26/07Global Blood Therapeutics Secures Marketing Approval for Anemia Drug in Great Britain
26/07MHRA Grants Marketing Authorization for GBT's Oxbryta® (voxelotor) for Use in Great Bri..
26/07MHRA Grants Marketing Authorization for GBT's Oxbryta® (voxelotor) for Use in Great Bri..
14/07Global Blood Therapeutics : GBT Initiates Expanded Access Program for Voxelotor in Patient..
14/07Global Blood Therapeutics, Inc. : Other Events, Financial Statements and Exhibits (form 8-..
14/07Global Blood Therapeutics Starts Expanded Access Program for Voxelotor in Brazil to Tre..
14/07Global Blood Therapeutics, Inc. Initiates Expanded Access Program for Voxelotor in Pati..
14/07GBT Initiates Expanded Access Program for Voxelotor in Patients With Sickle Cell Diseas..
14/07Global Blood Therapeutics, Inc. - The GBT Foundation Awards $250,000 in ACE Grants to S..
13/07The GBT Foundation Awards $250,000 in ACE Grants to Support Sickle Cell Disease Communi..
07/07GBT Announces New Employment Inducement Grants
29/06Sector Update: Health Care Stocks Ending Near Session Highs
29/06Sector Update: Health Care
29/06Global Blood Therapeutics Starts Phase 2 Trial of Sickle Cell Disease Drug
29/06Global Blood Therapeutics : Phase 2 portion designed to identify the optimal dose for the ..
29/06Global Blood Therapeutics, Inc. : Other Events, Financial Statements and Exhibits (form 8-..
29/06GBT Initiates Phase 2/3 Clinical Trial of GBT601 in Patients with Sickle Cell Disease
29/06Global Blood Therapeutics, Inc. Initiates Phase 2/3 Clinical Trial of GBT601 in Patient..
27/06Global Blood Therapeutics : driving innovation in sickle cell disease
16/06NFL Running Back Tevin Coleman and Family Team Up with GBT to Share Playbook for Famili..
15/06Global Blood Therapeutics, Inc. : Submission of Matters to a Vote of Security Holders (for..
15/06Transcript : Global Blood Therapeutics, Inc. Presents at Goldman Sachs 43rd A..
13/06Global Blood Therapeutics : Sickle Cell Health Awareness, Perspectives and Experiences (SH..
13/06Global Blood Therapeutics, Inc. : Other Events, Financial Statements and Exhibits (form 8-..
13/06New GBT Multinational Survey Shines a Needed Light on the Misunderstood Realities, Unse..
13/06New GBT Multinational Survey Shines a Needed Light on the Misunderstood Realities, Unse..
10/06Transcript : Global Blood Therapeutics, Inc. - Special Call
10/06Global Blood Therapeutics : GBT Presents Positive New Real-World Evidence Data at EHA2022 ..
10/06Global Blood Therapeutics, Inc. : Other Events, Financial Statements and Exhibits (form 8-..
Volgende evenement op GLOBAL BLOOD THERAPEUTICS, INC.